Good info guys. Since Covid we see a large influx with IVD analyzers in clinics and physician practices. Do you see this business growing over the years. not necessarily Covid testing but other disease states or ID testing and panels? Or do you think cost/ regulatory vs reimbursement will kill the business model?
Good info guys. Since Covid we see a large influx with IVD analyzers in clinics and physician practices. Do you see this business growing over the years. not necessarily Covid testing but other disease states or ID testing and panels? Or do you think cost/ regulatory vs reimbursement will kill the business model?